- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02466971
Prueba de la adición de un nuevo fármaco contra el cáncer, triapina, al tratamiento de quimioterapia habitual (cisplatino) durante la radioterapia para los cánceres de cuello uterino y de vagina en etapa avanzada
Un ensayo aleatorizado de fase III de radioterapia y cisplatino solos o en combinación con triapina intravenosa en mujeres con cáncer de cuello uterino en estadio IB2, estadio II, IIIB o IVA voluminoso recientemente diagnosticado o cáncer de vagina en estadio II-IVA
This randomized phase III trial studies radiation therapy and cisplatin with triapine to see how well they work compared to the standard radiation therapy and cisplatin alone in treating patients with newly diagnosed stage IB2, II, or IIIB-IVA cervical cancer or stage II-IVA vaginal cancer. Radiation therapy uses high energy protons to kill tumor cells and shrink tumors. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Triapine may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether radiation therapy and cisplatin are more effective with triapine in treating cervical or vaginal cancer.
Descripción general del estudio
Estado
Condiciones
- Adenocarcinoma de cuello uterino
- Carcinoma adenoescamoso de cuello uterino
- Adenocarcinoma vaginal avanzado
- Carcinoma adenoescamoso vaginal avanzado
- Carcinoma avanzado de células escamosas vaginales
- Carcinoma de células escamosas de cuello uterino
- Cáncer de cuello uterino en estadio IB2 AJCC v6 y v7
- Cáncer de cuello uterino en estadio II AJCC v7
- Cáncer de vagina en estadio II AJCC v6 y v7
- Cáncer de cuello uterino en estadio IIA AJCC v7
- Cáncer de cuello uterino en estadio IIB AJCC v6 y v7
- Cáncer de vagina en estadio III AJCC v6 y v7
- Cáncer de cuello uterino en estadio IIIB AJCC v6 y v7
- Cáncer de vagina en estadio IV AJCC v6 y v7
- Cáncer de cuello uterino en estadio IVA AJCC v6 y v7
- Cáncer de vagina en estadio IVA AJCC v6 y v7
- Carcinoma vaginal irresecable
- Adenocarcinoma vaginal
- Carcinoma adenoescamoso vaginal
- Carcinoma vaginal
- Carcinoma vaginal de células escamosas, no especificado
Descripción detallada
PRIMARY OBJECTIVE:
I. To evaluate the efficacy of the experimental regimen of triapine (3AP), cisplatin, and radiation to increase overall survival relative to the standard/control regimen of cisplatin and radiation in women with uterine cervix or vaginal cancer.
SECONDARY OBJECTIVE:
I. To determine the relative progression-free survival impact of triapine-cisplatin radio-chemotherapy and cisplatin radio-chemotherapy.
TERTIARY OBJECTIVES:
I. To evaluate incidence and severity of hematologic and gastrointestinal (GI) adverse events by radiation modality; image guided intensity modulated radiation therapy (IG-IMRT) versus conventional pelvic radiotherapy. (05/30/2017) II. To summarize and compare differences in acute adverse events (Common Terminology Criteria for Adverse Events [CTCAE], version [v]4.0) by treatment arm and by radiation modality. (05/30/2017) III. To summarize and compare differences in chronic or late (>= 30-days from off study treatment date) adverse events (CTCAE, v4.0) by treatment arm and by radiation modality. (05/30/2017) IV. To determine peripheral blood methemoglobin proportion before and after triapine infusion (optional for Arm 2 patients).
V. To explore whether knowledge-based planning (KBP) can improve IG-IMRT plans compared to plans that would have been delivered without KBP, estimate the resulting toxicity reduction using normal tissue complication probability (NTCP) models, and determine whether KBP should be a requirement for future IG-IMRT protocols.
VI. To determine the post-therapy 3-month fludeoxyglucose F-18 (18F-FDG) PET/CT metabolic complete response rate by treatment arm VII. To compare acute toxicity and chemotherapy delivery for atlas-based IG-IMRT vs. positron emission tomography (PET)/computed tomography (CT)-based IG-IMRT vs. conventional radiation therapy (RT), and assess the impact of treatment on changes in hematopoietic compensatory response.
VIII. To develop and validate machine learning and radiomics techniques for dose accumulation, automated treatment planning, and prediction of treatment response.
OUTLINE: Patients are randomized to 1 of 2 treatment arms.
ARM I: Patients receive cisplatin intravenously (IV) over 90 minutes on days 2, 9, 16, 23, 30, (and day 36 or 37 at the treating physician's discretion). Patients then undergo external beam radiation therapy (EBRT) (either conventional RT or intensity modulated radiation therapy [IMRT]) once daily (QD) 5 days a week for 25 fractions followed by low dose rate (LDR) or high dose rate (HDR) brachytherapy according to institution's standards. Treatment continues in the absence of disease progression or unacceptable toxicity.
ARM II: Patients receive cisplatin and undergo EBRT followed by brachytherapy as in Arm I. Patients also receive triapine IV over 2 hours on days 1, 3, 5, 8, 10, 12, 15, 17, 19, 22, 24, 26, 29, 31, and 33. Treatment continues in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up at 1 and 3 months, every 3 months for 2 years, and then every 6 months for 3 years.
The patient data from NCI #9434 will be merged with NRG-GY006 per the Protocol Analysis Plan.
Tipo de estudio
Inscripción (Actual)
Fase
- Fase 3
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Ontario
-
Toronto, Ontario, Canadá, M4N 3M5
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
-
-
-
-
Alabama
-
Birmingham, Alabama, Estados Unidos, 35233
- University of Alabama at Birmingham Cancer Center
-
-
Alaska
-
Anchorage, Alaska, Estados Unidos, 98508
- Anchorage Associates in Radiation Medicine
-
Anchorage, Alaska, Estados Unidos, 99508
- Alaska Breast Care and Surgery LLC
-
Anchorage, Alaska, Estados Unidos, 99508
- Alaska Oncology and Hematology LLC
-
Anchorage, Alaska, Estados Unidos, 99508
- Alaska Women's Cancer Care
-
Anchorage, Alaska, Estados Unidos, 99508
- Anchorage Oncology Centre
-
Anchorage, Alaska, Estados Unidos, 99508
- Katmai Oncology Group
-
Anchorage, Alaska, Estados Unidos, 99508
- Providence Alaska Medical Center
-
Fairbanks, Alaska, Estados Unidos, 99701
- Fairbanks Memorial Hospital
-
-
Arizona
-
Tucson, Arizona, Estados Unidos, 85719
- Banner University Medical Center - Tucson
-
Tucson, Arizona, Estados Unidos, 85719
- University of Arizona Cancer Center-North Campus
-
-
Arkansas
-
Hot Springs, Arkansas, Estados Unidos, 71913
- CHI Saint Vincent Cancer Center Hot Springs
-
Little Rock, Arkansas, Estados Unidos, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Antioch, California, Estados Unidos, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Burbank, California, Estados Unidos, 91505
- Providence Saint Joseph Medical Center/Disney Family Cancer Center
-
Fremont, California, Estados Unidos, 94538
- Kaiser Permanente-Fremont
-
Fresno, California, Estados Unidos, 93720
- Kaiser Permanente-Fresno
-
La Jolla, California, Estados Unidos, 92093
- UC San Diego Moores Cancer Center
-
Los Angeles, California, Estados Unidos, 90033
- Los Angeles General Medical Center
-
Modesto, California, Estados Unidos, 95356
- Kaiser Permanente-Modesto
-
Oakland, California, Estados Unidos, 94611
- Kaiser Permanente-Oakland
-
Oakland, California, Estados Unidos, 94611
- Kaiser Permanente Oakland-Broadway
-
Orange, California, Estados Unidos, 92868
- UC Irvine Health/Chao Family Comprehensive Cancer Center
-
Rancho Cordova, California, Estados Unidos, 95670
- Kaiser Permanente-Rancho Cordova Cancer Center
-
Redwood City, California, Estados Unidos, 94063
- Kaiser Permanente-Redwood City
-
Richmond, California, Estados Unidos, 94801
- Kaiser Permanente-Richmond
-
Rohnert Park, California, Estados Unidos, 94928
- Rohnert Park Cancer Center
-
Roseville, California, Estados Unidos, 95678
- The Permanente Medical Group-Roseville Radiation Oncology
-
Roseville, California, Estados Unidos, 95661
- Kaiser Permanente-Roseville
-
Sacramento, California, Estados Unidos, 95817
- University of California Davis Comprehensive Cancer Center
-
Sacramento, California, Estados Unidos, 95823
- Kaiser Permanente-South Sacramento
-
Sacramento, California, Estados Unidos, 95823
- South Sacramento Cancer Center
-
Sacramento, California, Estados Unidos, 95825
- Kaiser Permanente Sacramento Medical Center
-
San Francisco, California, Estados Unidos, 94115
- Kaiser Permanente-San Francisco
-
San Jose, California, Estados Unidos, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Leandro, California, Estados Unidos, 94577
- Kaiser Permanente San Leandro
-
San Rafael, California, Estados Unidos, 94903
- Kaiser San Rafael-Gallinas
-
San Rafael, California, Estados Unidos, 94903
- Kaiser Permanente-San Rafael
-
Santa Clara, California, Estados Unidos, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, Estados Unidos, 95403
- Kaiser Permanente-Santa Rosa
-
South San Francisco, California, Estados Unidos, 94080
- Kaiser Permanente Cancer Treatment Center
-
South San Francisco, California, Estados Unidos, 94080
- Kaiser Permanente-South San Francisco
-
Stockton, California, Estados Unidos, 95210
- Kaiser Permanente-Stockton
-
Truckee, California, Estados Unidos, 96161
- Gene Upshaw Memorial Tahoe Forest Cancer Center
-
Vacaville, California, Estados Unidos, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, Estados Unidos, 94589
- Kaiser Permanente-Vallejo
-
Walnut Creek, California, Estados Unidos, 94596
- Kaiser Permanente-Walnut Creek
-
-
Colorado
-
Aurora, Colorado, Estados Unidos, 80045
- UCHealth University of Colorado Hospital
-
Colorado Springs, Colorado, Estados Unidos, 80907
- Penrose-Saint Francis Healthcare
-
Colorado Springs, Colorado, Estados Unidos, 80907
- Rocky Mountain Cancer Centers-Penrose
-
Denver, Colorado, Estados Unidos, 80210
- AdventHealth Porter
-
Lakewood, Colorado, Estados Unidos, 80228
- CommonSpirit Saint Anthony Hospital Cancer Center
-
Littleton, Colorado, Estados Unidos, 80122
- AdventHealth Littleton
-
Longmont, Colorado, Estados Unidos, 80501
- Longmont United Hospital
-
Pueblo, Colorado, Estados Unidos, 81004
- Saint Mary Corwin Medical Center
-
Thornton, Colorado, Estados Unidos, 80260
- Rocky Mountain Cancer Centers-Thornton
-
-
Connecticut
-
Hartford, Connecticut, Estados Unidos, 06102
- Hartford Hospital
-
-
Delaware
-
Lewes, Delaware, Estados Unidos, 19958
- Beebe Medical Center
-
Newark, Delaware, Estados Unidos, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Estados Unidos, 19713
- Delaware Clinical and Laboratory Physicians PA
-
Newark, Delaware, Estados Unidos, 19713
- Medical Oncology Hematology Consultants PA
-
Newark, Delaware, Estados Unidos, 19718
- Christiana Care Health System-Christiana Hospital
-
-
Florida
-
Gainesville, Florida, Estados Unidos, 32610
- UF Health Cancer Institute - Gainesville
-
Jacksonville, Florida, Estados Unidos, 32224-9980
- Mayo Clinic in Florida
-
Lakeland, Florida, Estados Unidos, 33805
- Lakeland Regional Health Hollis Cancer Center
-
Tampa, Florida, Estados Unidos, 33612
- Moffitt Cancer Center
-
-
Georgia
-
Atlanta, Georgia, Estados Unidos, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, Estados Unidos, 30322
- Emory University Hospital/Winship Cancer Institute
-
Atlanta, Georgia, Estados Unidos, 30342
- Emory Saint Joseph's Hospital
-
Augusta, Georgia, Estados Unidos, 30912
- Augusta University Medical Center
-
Savannah, Georgia, Estados Unidos, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
Savannah, Georgia, Estados Unidos, 31404
- Memorial Health University Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, Estados Unidos, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Estados Unidos, 96817
- The Cancer Center of Hawaii-Liliha
-
Honolulu, Hawaii, Estados Unidos, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, Estados Unidos, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Estados Unidos, 96813
- University of Hawaii Cancer Center
-
Honolulu, Hawaii, Estados Unidos, 96817
- Hawaii Cancer Care Inc-Liliha
-
Honolulu, Hawaii, Estados Unidos, 96817
- Kuakini Medical Center
-
Honolulu, Hawaii, Estados Unidos, 96817
- Queen's Cancer Center - Kuakini
-
Honolulu, Hawaii, Estados Unidos, 96826
- Kapiolani Medical Center for Women and Children
-
Honolulu, Hawaii, Estados Unidos, 96813
- Island Urology
-
Honolulu, Hawaii, Estados Unidos, 96819
- Kaiser Permanente Moanalua Medical Center
-
Lihue, Hawaii, Estados Unidos, 96766
- Wilcox Memorial Hospital and Kauai Medical Clinic
-
‘Aiea, Hawaii, Estados Unidos, 96701
- Pali Momi Medical Center
-
‘Aiea, Hawaii, Estados Unidos, 96701
- Queen's Cancer Center - Pearlridge
-
‘Aiea, Hawaii, Estados Unidos, 96701
- The Cancer Center of Hawaii-Pali Momi
-
-
Idaho
-
Boise, Idaho, Estados Unidos, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise, Idaho, Estados Unidos, 83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell, Idaho, Estados Unidos, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Fruitland, Idaho, Estados Unidos, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, Estados Unidos, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, Estados Unidos, 83687
- Saint Luke's Cancer Institute - Nampa
-
Post Falls, Idaho, Estados Unidos, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Twin Falls, Idaho, Estados Unidos, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Bloomington, Illinois, Estados Unidos, 61701
- OSF Saint Joseph Medical Center
-
Carbondale, Illinois, Estados Unidos, 62902
- Memorial Hospital of Carbondale
-
Chicago, Illinois, Estados Unidos, 60611
- Northwestern University
-
Chicago, Illinois, Estados Unidos, 60612
- John H Stroger Jr Hospital of Cook County
-
Chicago, Illinois, Estados Unidos, 60612
- Rush MD Anderson Cancer Center
-
Decatur, Illinois, Estados Unidos, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Estados Unidos, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Effingham, Illinois, Estados Unidos, 62401
- Crossroads Cancer Center
-
Galesburg, Illinois, Estados Unidos, 61401
- Western Illinois Cancer Treatment Center
-
Geneva, Illinois, Estados Unidos, 60134
- Northwestern Medicine Cancer Center Delnor
-
Maywood, Illinois, Estados Unidos, 60153
- Loyola University Medical Center
-
Mount Vernon, Illinois, Estados Unidos, 62864
- SSM Health Good Samaritan
-
O'Fallon, Illinois, Estados Unidos, 62269
- Cancer Care Center of O'Fallon
-
Ottawa, Illinois, Estados Unidos, 61350
- Illinois CancerCare-Ottawa Clinic
-
Ottawa, Illinois, Estados Unidos, 61350
- Radiation Oncology of Northern Illinois
-
Pekin, Illinois, Estados Unidos, 61554
- OSF Saint Francis Radiation Oncology at Pekin
-
Peoria, Illinois, Estados Unidos, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Estados Unidos, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, Estados Unidos, 61615
- Illinois CancerCare-Peoria
-
Peoria, Illinois, Estados Unidos, 61615
- OSF Saint Francis Radiation Oncology at Peoria Cancer Center
-
Peru, Illinois, Estados Unidos, 61354
- Illinois CancerCare-Peru
-
Peru, Illinois, Estados Unidos, 61354
- Valley Radiation Oncology
-
Princeton, Illinois, Estados Unidos, 61356
- Illinois CancerCare-Princeton
-
Springfield, Illinois, Estados Unidos, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Estados Unidos, 62702
- Springfield Clinic
-
Springfield, Illinois, Estados Unidos, 62702
- Central Illinois Hematology Oncology Center
-
Springfield, Illinois, Estados Unidos, 62781
- Springfield Memorial Hospital
-
Swansea, Illinois, Estados Unidos, 62226
- Southwest Illinois Health Services LLP
-
Urbana, Illinois, Estados Unidos, 61801
- Carle Cancer Center
-
Warrenville, Illinois, Estados Unidos, 60555
- Northwestern Medicine Cancer Center Warrenville
-
-
Indiana
-
Fort Wayne, Indiana, Estados Unidos, 46805
- Parkview Hospital Randallia
-
Fort Wayne, Indiana, Estados Unidos, 46845
- Parkview Regional Medical Center
-
Indianapolis, Indiana, Estados Unidos, 46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Indianapolis, Indiana, Estados Unidos, 46260
- Ascension Saint Vincent Indianapolis Hospital
-
Indianapolis, Indiana, Estados Unidos, 46202
- Sidney and Lois Eskenazi Hospital
-
Richmond, Indiana, Estados Unidos, 47374
- Reid Health
-
-
Iowa
-
Cedar Rapids, Iowa, Estados Unidos, 52403
- Mercy Hospital
-
Cedar Rapids, Iowa, Estados Unidos, 52403
- Oncology Associates at Mercy Medical Center
-
Clive, Iowa, Estados Unidos, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Estados Unidos, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Des Moines, Iowa, Estados Unidos, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Estados Unidos, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Estados Unidos, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, Estados Unidos, 50309
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Des Moines, Iowa, Estados Unidos, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
West Des Moines, Iowa, Estados Unidos, 50266-7700
- Methodist West Hospital
-
West Des Moines, Iowa, Estados Unidos, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Garden City, Kansas, Estados Unidos, 67846
- Saint Catherine Hospital
-
Great Bend, Kansas, Estados Unidos, 67530
- Saint Rose Ambulatory and Surgery Center
-
Hays, Kansas, Estados Unidos, 67601
- HaysMed
-
Kansas City, Kansas, Estados Unidos, 66160
- University of Kansas Cancer Center
-
Olathe, Kansas, Estados Unidos, 66061
- The University of Kansas Cancer Center - Olathe
-
Overland Park, Kansas, Estados Unidos, 66210
- University of Kansas Cancer Center-Overland Park
-
Pittsburg, Kansas, Estados Unidos, 66762
- Mercy Hospital Pittsburg
-
Salina, Kansas, Estados Unidos, 67401
- Salina Regional Health Center
-
Topeka, Kansas, Estados Unidos, 66606
- University of Kansas Health System Saint Francis Campus
-
-
Kentucky
-
Lexington, Kentucky, Estados Unidos, 40536
- University of Kentucky/Markey Cancer Center
-
Lexington, Kentucky, Estados Unidos, 40504
- Saint Joseph Radiation Oncology Resource Center
-
Lexington, Kentucky, Estados Unidos, 40509
- CommonSpirit Saint Joseph Medical Center - East Lexington
-
Louisville, Kentucky, Estados Unidos, 40202
- The James Graham Brown Cancer Center at University of Louisville
-
Louisville, Kentucky, Estados Unidos, 40202
- Jewish Hospital
-
Louisville, Kentucky, Estados Unidos, 40245
- UofL Health Medical Center Northeast
-
-
Louisiana
-
Metairie, Louisiana, Estados Unidos, 70006
- East Jefferson General Hospital
-
New Orleans, Louisiana, Estados Unidos, 70121
- Ochsner Medical Center Jefferson
-
New Orleans, Louisiana, Estados Unidos, 70112
- University Medical Center New Orleans
-
-
Maryland
-
Baltimore, Maryland, Estados Unidos, 21204
- Greater Baltimore Medical Center
-
Bethesda, Maryland, Estados Unidos, 20889-5600
- Walter Reed National Military Medical Center
-
-
Michigan
-
Brownstown, Michigan, Estados Unidos, 48183
- Henry Ford Cancer Institute-Downriver
-
Clinton Township, Michigan, Estados Unidos, 48038
- Henry Ford Macomb Hospital-Clinton Township
-
Detroit, Michigan, Estados Unidos, 48202
- Henry Ford Hospital
-
Detroit, Michigan, Estados Unidos, 48201
- Wayne State University/Karmanos Cancer Institute
-
Farmington Hills, Michigan, Estados Unidos, 48334
- Weisberg Cancer Treatment Center
-
Grand Rapids, Michigan, Estados Unidos, 49503
- Trinity Health Grand Rapids Hospital
-
Grand Rapids, Michigan, Estados Unidos, 49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Kalamazoo, Michigan, Estados Unidos, 49007
- West Michigan Cancer Center
-
Kalamazoo, Michigan, Estados Unidos, 49007
- Bronson Methodist Hospital
-
Kalamazoo, Michigan, Estados Unidos, 49048
- Beacon Kalamazoo
-
Muskegon, Michigan, Estados Unidos, 49444
- Trinity Health Muskegon Hospital
-
Reed City, Michigan, Estados Unidos, 49677
- Corewell Health Reed City Hospital
-
Saint Joseph, Michigan, Estados Unidos, 49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Traverse City, Michigan, Estados Unidos, 49684
- Munson Medical Center
-
West Bloomfield, Michigan, Estados Unidos, 48322
- Henry Ford West Bloomfield Hospital
-
Wyoming, Michigan, Estados Unidos, 49519
- University of Michigan Health - West
-
-
Minnesota
-
Minneapolis, Minnesota, Estados Unidos, 55455
- University of Minnesota/Masonic Cancer Center
-
Rochester, Minnesota, Estados Unidos, 55905
- Mayo Clinic in Rochester
-
-
Mississippi
-
Jackson, Mississippi, Estados Unidos, 39216
- University of Mississippi Medical Center
-
-
Missouri
-
Ballwin, Missouri, Estados Unidos, 63011
- Mercy Oncology and Hematology - Clayton-Clarkson
-
Cape Girardeau, Missouri, Estados Unidos, 63703
- Saint Francis Medical Center
-
Cape Girardeau, Missouri, Estados Unidos, 63703
- Mercy Cancer Center - Cape Girardeau
-
Jefferson City, Missouri, Estados Unidos, 65109
- MU Health Care Goldschmidt Cancer Center
-
Joplin, Missouri, Estados Unidos, 64804
- Freeman Health System
-
Kansas City, Missouri, Estados Unidos, 64154
- University of Kansas Cancer Center - North
-
Kansas City, Missouri, Estados Unidos, 64116
- North Kansas City Hospital
-
Kansas City, Missouri, Estados Unidos, 64131
- The University of Kansas Cancer Center-South
-
Lee's Summit, Missouri, Estados Unidos, 64064
- University of Kansas Cancer Center - Lee's Summit
-
Rolla, Missouri, Estados Unidos, 65401
- Mercy Clinic-Rolla-Cancer and Hematology
-
Rolla, Missouri, Estados Unidos, 65401
- Phelps Health Delbert Day Cancer Institute
-
Springfield, Missouri, Estados Unidos, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, Estados Unidos, 65804
- Mercy Hospital Springfield
-
St Louis, Missouri, Estados Unidos, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, Estados Unidos, 63141
- Mercy Hospital Saint Louis
-
-
Montana
-
Billings, Montana, Estados Unidos, 59101
- Billings Clinic Cancer Center
-
Billings, Montana, Estados Unidos, 59101
- Saint Vincent Healthcare
-
Bozeman, Montana, Estados Unidos, 59715
- Bozeman Health Deaconess Hospital
-
Butte, Montana, Estados Unidos, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, Estados Unidos, 59405
- Great Falls Clinic
-
Great Falls, Montana, Estados Unidos, 59405
- Benefis Sletten Cancer Institute
-
Kalispell, Montana, Estados Unidos, 59901
- Logan Health Medical Center
-
Missoula, Montana, Estados Unidos, 59804
- Community Medical Center
-
-
Nebraska
-
Grand Island, Nebraska, Estados Unidos, 68803
- Nebraska Cancer Specialists/Oncology Hematology West PC
-
Kearney, Nebraska, Estados Unidos, 68847
- CHI Health Good Samaritan
-
Omaha, Nebraska, Estados Unidos, 68114
- Nebraska Methodist Hospital
-
Omaha, Nebraska, Estados Unidos, 68198
- University of Nebraska Medical Center
-
Omaha, Nebraska, Estados Unidos, 68124
- Alegent Health Bergan Mercy Medical Center
-
Omaha, Nebraska, Estados Unidos, 68122
- Alegent Health Immanuel Medical Center
-
Omaha, Nebraska, Estados Unidos, 68130
- Alegent Health Lakeside Hospital
-
Papillion, Nebraska, Estados Unidos, 68046
- Midlands Community Hospital
-
-
Nevada
-
Las Vegas, Nevada, Estados Unidos, 89106
- Radiation Oncology Centers of Nevada Central
-
Las Vegas, Nevada, Estados Unidos, 89106
- Women's Cancer Center of Nevada
-
Reno, Nevada, Estados Unidos, 89502
- Renown Regional Medical Center
-
Reno, Nevada, Estados Unidos, 89502
- Center of Hope at Renown Medical Center
-
-
New Jersey
-
Camden, New Jersey, Estados Unidos, 08103
- Cooper Hospital University Medical Center
-
Mount Holly, New Jersey, Estados Unidos, 08060
- Virtua Memorial
-
Mount Laurel, New Jersey, Estados Unidos, 08054
- Cooper CyberKnife Center
-
New Brunswick, New Jersey, Estados Unidos, 08903
- Rutgers Cancer Institute of New Jersey
-
Newark, New Jersey, Estados Unidos, 07101
- Rutgers New Jersey Medical School
-
Somerville, New Jersey, Estados Unidos, 08876
- Robert Wood Johnson University Hospital Somerset
-
Voorhees Township, New Jersey, Estados Unidos, 08043
- MD Anderson Cancer Center at Cooper-Voorhees
-
Voorhees Township, New Jersey, Estados Unidos, 08043
- Virtua Voorhees
-
-
New Mexico
-
Albuquerque, New Mexico, Estados Unidos, 87106
- Southwest Gynecologic Oncology Associates Inc
-
Albuquerque, New Mexico, Estados Unidos, 87106
- University of New Mexico Cancer Center
-
Las Cruces, New Mexico, Estados Unidos, 88011
- Memorial Medical Center-Las Cruces
-
-
New York
-
Albany, New York, Estados Unidos, 12208
- Saint Peter's Health Partners
-
Albany, New York, Estados Unidos, 12208
- Women's Cancer Care Associates LLC
-
Brooklyn, New York, Estados Unidos, 11219
- Maimonides Medical Center
-
Buffalo, New York, Estados Unidos, 14263
- Roswell Park Cancer Institute
-
New York, New York, Estados Unidos, 10011
- Mount Sinai Chelsea
-
New York, New York, Estados Unidos, 10016
- Laura and Isaac Perlmutter Cancer Center at NYU Langone
-
Rochester, New York, Estados Unidos, 14642
- University of Rochester
-
Rochester, New York, Estados Unidos, 14620
- Highland Hospital
-
Syracuse, New York, Estados Unidos, 13210
- State University of New York Upstate Medical University
-
-
North Carolina
-
Charlotte, North Carolina, Estados Unidos, 28204
- Novant Health Presbyterian Medical Center
-
Winston-Salem, North Carolina, Estados Unidos, 27157
- Wake Forest University Health Sciences
-
-
Ohio
-
Akron, Ohio, Estados Unidos, 44304
- Summa Health System - Akron Campus
-
Beachwood, Ohio, Estados Unidos, 44122
- UHHS-Chagrin Highlands Medical Center
-
Canton, Ohio, Estados Unidos, 44710
- Aultman Health Foundation
-
Centerville, Ohio, Estados Unidos, 45459
- Miami Valley Hospital South
-
Chardon, Ohio, Estados Unidos, 44024
- Geauga Hospital
-
Chillicothe, Ohio, Estados Unidos, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, Estados Unidos, 45219
- University of Cincinnati Cancer Center-UC Medical Center
-
Cincinnati, Ohio, Estados Unidos, 45220
- Good Samaritan Hospital - Cincinnati
-
Cincinnati, Ohio, Estados Unidos, 45242
- Bethesda North Hospital
-
Cincinnati, Ohio, Estados Unidos, 45242
- Oncology Hematology Care Inc-Blue Ash
-
Cleveland, Ohio, Estados Unidos, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Estados Unidos, 44109
- MetroHealth Medical Center
-
Cleveland, Ohio, Estados Unidos, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, Estados Unidos, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus, Ohio, Estados Unidos, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Estados Unidos, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Estados Unidos, 43228
- Doctors Hospital
-
Columbus, Ohio, Estados Unidos, 43213
- Mount Carmel East Hospital
-
Columbus, Ohio, Estados Unidos, 43215
- Grant Medical Center
-
Columbus, Ohio, Estados Unidos, 43222
- Mount Carmel Health Center West
-
Dayton, Ohio, Estados Unidos, 45406
- Good Samaritan Hospital - Dayton
-
Dayton, Ohio, Estados Unidos, 45409
- Miami Valley Hospital
-
Dayton, Ohio, Estados Unidos, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, Estados Unidos, 45415
- Dayton Physician LLC - Englewood
-
Delaware, Ohio, Estados Unidos, 43015
- Delaware Radiation Oncology
-
Delaware, Ohio, Estados Unidos, 43015
- Grady Memorial Hospital
-
Findlay, Ohio, Estados Unidos, 45840
- Blanchard Valley Hospital
-
Franklin, Ohio, Estados Unidos, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Greenville, Ohio, Estados Unidos, 45331
- Wayne Hospital
-
Kettering, Ohio, Estados Unidos, 45429
- Kettering Medical Center
-
Mansfield, Ohio, Estados Unidos, 44903
- OhioHealth Mansfield Hospital
-
Marietta, Ohio, Estados Unidos, 45750
- Marietta Memorial Hospital
-
Mayfield Heights, Ohio, Estados Unidos, 44124
- Hillcrest Hospital Cancer Center
-
Mentor, Ohio, Estados Unidos, 44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Newark, Ohio, Estados Unidos, 43055
- Licking Memorial Hospital
-
Newark, Ohio, Estados Unidos, 43055
- Newark Radiation Oncology
-
Portsmouth, Ohio, Estados Unidos, 45662
- Southern Ohio Medical Center
-
Springfield, Ohio, Estados Unidos, 45504
- Springfield Regional Medical Center
-
Sylvania, Ohio, Estados Unidos, 43560
- ProMedica Flower Hospital
-
Toledo, Ohio, Estados Unidos, 43606
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
-
Troy, Ohio, Estados Unidos, 45373
- Upper Valley Medical Center
-
Wadsworth, Ohio, Estados Unidos, 44281
- University Hospitals Sharon Health Center
-
West Chester, Ohio, Estados Unidos, 45069
- University of Cincinnati Cancer Center-West Chester
-
Westerville, Ohio, Estados Unidos, 43081
- Saint Ann's Hospital
-
Westlake, Ohio, Estados Unidos, 44145
- UH Seidman Cancer Center at Saint John Medical Center
-
Westlake, Ohio, Estados Unidos, 44145
- UHHS-Westlake Medical Center
-
Zanesville, Ohio, Estados Unidos, 43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Estados Unidos, 73104
- University of Oklahoma Health Sciences Center
-
Tulsa, Oklahoma, Estados Unidos, 74146
- Oklahoma Cancer Specialists and Research Institute-Tulsa
-
-
Oregon
-
Bend, Oregon, Estados Unidos, 97701
- Saint Charles Health System
-
Clackamas, Oregon, Estados Unidos, 97015
- Clackamas Radiation Oncology Center
-
Coos Bay, Oregon, Estados Unidos, 97420
- Bay Area Hospital
-
Gresham, Oregon, Estados Unidos, 97030
- Legacy Mount Hood Medical Center
-
Portland, Oregon, Estados Unidos, 97239
- Oregon Health and Science University
-
Portland, Oregon, Estados Unidos, 97210
- Legacy Good Samaritan Hospital and Medical Center
-
Portland, Oregon, Estados Unidos, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Estados Unidos, 97225
- Providence Saint Vincent Medical Center
-
Tualatin, Oregon, Estados Unidos, 97062
- Legacy Meridian Park Hospital
-
-
Pennsylvania
-
Abington, Pennsylvania, Estados Unidos, 19001
- Jefferson Abington Hospital
-
Beaver, Pennsylvania, Estados Unidos, 15009
- UPMC-Heritage Valley Health System Beaver
-
Chadds Ford, Pennsylvania, Estados Unidos, 19317
- Christiana Care Health System-Concord Health Center
-
Dunmore, Pennsylvania, Estados Unidos, 18512
- Northeast Radiation Oncology Center
-
Ephrata, Pennsylvania, Estados Unidos, 17522
- Ephrata Cancer Center
-
Gettysburg, Pennsylvania, Estados Unidos, 17325
- Adams Cancer Center
-
Greensburg, Pennsylvania, Estados Unidos, 15601
- UPMC Cancer Centers - Arnold Palmer Pavilion
-
Hanover, Pennsylvania, Estados Unidos, 17331
- WellSpan Medical Oncology and Hematology
-
Moon Township, Pennsylvania, Estados Unidos, 15108
- UPMC Hillman Cancer Center in Coraopolis
-
Philadelphia, Pennsylvania, Estados Unidos, 19107
- Thomas Jefferson University Hospital
-
Pittsburgh, Pennsylvania, Estados Unidos, 15232
- UPMC Hillman Cancer Center
-
Pittsburgh, Pennsylvania, Estados Unidos, 15213
- UPMC-Magee Womens Hospital
-
Pittsburgh, Pennsylvania, Estados Unidos, 15232
- UPMC-Shadyside Hospital
-
West Reading, Pennsylvania, Estados Unidos, 19611
- Reading Hospital
-
Willow Grove, Pennsylvania, Estados Unidos, 19090
- Asplundh Cancer Pavilion
-
Wynnewood, Pennsylvania, Estados Unidos, 19096
- Lankenau Medical Center
-
York, Pennsylvania, Estados Unidos, 17403
- WellSpan Health-York Cancer Center
-
York, Pennsylvania, Estados Unidos, 17403
- WellSpan Health-York Hospital
-
-
Rhode Island
-
Providence, Rhode Island, Estados Unidos, 02905
- Women and Infants Hospital
-
-
South Carolina
-
Greenville, South Carolina, Estados Unidos, 29605
- Prisma Health Cancer Institute - Faris
-
Greenville, South Carolina, Estados Unidos, 29607
- Saint Francis Cancer Center
-
Greenville, South Carolina, Estados Unidos, 29601
- Saint Francis Hospital
-
Spartanburg, South Carolina, Estados Unidos, 29303
- Spartanburg Medical Center
-
-
South Dakota
-
Rapid City, South Dakota, Estados Unidos, 57701
- Rapid City Regional Hospital
-
-
Tennessee
-
Chattanooga, Tennessee, Estados Unidos, 37404
- Memorial Hospital
-
Nashville, Tennessee, Estados Unidos, 37232
- Vanderbilt University/Ingram Cancer Center
-
-
Texas
-
Bryan, Texas, Estados Unidos, 77802
- Saint Joseph Regional Cancer Center
-
Dallas, Texas, Estados Unidos, 75235
- Parkland Memorial Hospital
-
Dallas, Texas, Estados Unidos, 75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
Houston, Texas, Estados Unidos, 77030
- Houston Methodist Hospital
-
Houston, Texas, Estados Unidos, 77030
- Memorial Hermann Texas Medical Center
-
Houston, Texas, Estados Unidos, 77070
- Methodist Willowbrook Hospital
-
Sugar Land, Texas, Estados Unidos, 77479
- Houston Methodist Sugar Land Hospital
-
The Woodlands, Texas, Estados Unidos, 77385
- Houston Methodist The Woodlands Hospital
-
-
Utah
-
Cedar City, Utah, Estados Unidos, 84720
- Sandra L Maxwell Cancer Center
-
Logan, Utah, Estados Unidos, 84321
- Logan Regional Hospital
-
Murray, Utah, Estados Unidos, 84107
- Intermountain Medical Center
-
Ogden, Utah, Estados Unidos, 84403
- McKay-Dee Hospital Center
-
Provo, Utah, Estados Unidos, 84604
- Utah Valley Regional Medical Center
-
Salt Lake City, Utah, Estados Unidos, 84112
- Huntsman Cancer Institute/University of Utah
-
Salt Lake City, Utah, Estados Unidos, 84106
- Utah Cancer Specialists-Salt Lake City
-
Salt Lake City, Utah, Estados Unidos, 84143
- LDS Hospital
-
South Jordan, Utah, Estados Unidos, 84009
- South Jordan Health Center
-
St. George, Utah, Estados Unidos, 84770
- Saint George Regional Medical Center
-
-
Washington
-
Aberdeen, Washington, Estados Unidos, 98520
- Providence Regional Cancer System-Aberdeen
-
Auburn, Washington, Estados Unidos, 98001
- MultiCare Auburn Medical Center
-
Bellevue, Washington, Estados Unidos, 98004
- Overlake Medical Center
-
Bellingham, Washington, Estados Unidos, 98225
- PeaceHealth Saint Joseph Medical Center
-
Burien, Washington, Estados Unidos, 98166
- Saint Anne Hospital
-
Centralia, Washington, Estados Unidos, 98531
- Providence Regional Cancer System-Centralia
-
Everett, Washington, Estados Unidos, 98201
- Providence Regional Cancer Partnership
-
Federal Way, Washington, Estados Unidos, 98002
- Virginia Mason Federal Way Medical Center
-
Gig Harbor, Washington, Estados Unidos, 98332
- Tacoma/Valley Radiation Oncology Centers-Gig Harbor
-
Gig Harbor, Washington, Estados Unidos, 98335
- MultiCare Gig Harbor Medical Park
-
Issaquah, Washington, Estados Unidos, 98029
- Swedish Cancer Institute-Issaquah
-
Lacey, Washington, Estados Unidos, 98503
- Providence Regional Cancer System-Lacey
-
Longview, Washington, Estados Unidos, 98632
- PeaceHealth Saint John Medical Center
-
Puyallup, Washington, Estados Unidos, 98372
- MultiCare Good Samaritan Hospital
-
Puyallup, Washington, Estados Unidos, 98372
- Tacoma/Valley Radiation Oncology Centers-Puyallup
-
Seattle, Washington, Estados Unidos, 98101
- Virginia Mason Medical Center
-
Seattle, Washington, Estados Unidos, 98122
- Swedish Medical Center-First Hill
-
Seattle, Washington, Estados Unidos, 98112
- Kaiser Permanente Washington
-
Seattle, Washington, Estados Unidos, 98109
- Fred Hutchinson Cancer Center
-
Silverdale, Washington, Estados Unidos, 98383
- Saint Joseph Medical Center Hematology and Oncology - Silverdale
-
Tacoma, Washington, Estados Unidos, 98405
- Northwest Medical Specialties PLLC
-
Tacoma, Washington, Estados Unidos, 98405
- MultiCare Tacoma General Hospital
-
Tacoma, Washington, Estados Unidos, 98405
- Tacoma/Valley Radiation Oncology Centers-Saint Joe's
-
Vancouver, Washington, Estados Unidos, 98686
- Legacy Salmon Creek Hospital
-
Vancouver, Washington, Estados Unidos, 98664
- PeaceHealth Southwest Medical Center
-
Walla Walla, Washington, Estados Unidos, 99362
- Providence Saint Mary Regional Cancer Center
-
Yakima, Washington, Estados Unidos, 98902
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
-
-
West Virginia
-
Huntington, West Virginia, Estados Unidos, 25701
- Edwards Comprehensive Cancer Center
-
Morgantown, West Virginia, Estados Unidos, 26506
- West Virginia University Healthcare
-
Wheeling, West Virginia, Estados Unidos, 26003
- Wheeling Hospital/Schiffler Cancer Center
-
-
Wisconsin
-
Eau Claire, Wisconsin, Estados Unidos, 54701
- Marshfield Medical Center-EC Cancer Center
-
Madison, Wisconsin, Estados Unidos, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Marshfield, Wisconsin, Estados Unidos, 54449
- Marshfield Medical Center-Marshfield
-
Milwaukee, Wisconsin, Estados Unidos, 53226
- Medical College of Wisconsin
-
Minocqua, Wisconsin, Estados Unidos, 54548
- Marshfield Medical Center - Minocqua
-
Stevens Point, Wisconsin, Estados Unidos, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Weston, Wisconsin, Estados Unidos, 54476
- Marshfield Medical Center - Weston
-
-
-
-
-
San Juan, Puerto Rico, 00917
- San Juan Community Oncology Group
-
San Juan, Puerto Rico, 00927
- Centro Comprensivo de Cancer de UPR
-
San Juan, Puerto Rico, 00936
- San Juan City Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
-
Patient has a new, unrated histologic diagnosis of stage IB2 (> 4 cm), II, IIIB or IVA squamous, adenocarcinoma, or adenosquamous carcinoma of the uterine cervix (FIGO 2009) or stage II-IVA squamous, adenocarcinoma, or adenosquamous carcinoma of the vagina not amenable to curative surgical resection alone; the presence or absence of para-aortic lymph node metastasis will be based on pre-therapy 18F-FDG PET/CT; NOTE: if the baseline 18F-FDG PET/CT identifies hypermetabolic para-aortic disease, such patients will NOT be eligible; the patient must be able to tolerate imaging requirements of an 18F-FDG PET/CT scan
-
Patient must provide study specific informed consent prior to study entry
-
Patient must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2 or equivalent
-
Absolute neutrophil count > 1,500/uL
-
Platelets > 100,000/uL
-
Hemoglobin > 10 g/dL
-
Total bilirubin < 2.0 mg/dL
-
Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) < 2.5 X institutional upper limit of normal
-
Prothrombin time (PT)/activated partial thromboplastin time (aPTT) < 1.5 X institutional upper limit of normal
-
Creatinine =< 1.5 mg/dL to receive weekly cisplatin
- Patients whose serum creatinine is between 1.5 and 1.9 mg/dL are eligible for cisplatin if the estimated creatinine clearance (CCr) is >= 30 ml/min; for the purpose of estimating the CCr, the formula of Cockcroft and Gault for females should be used
-
Patient does not have uncontrolled diabetes mellitus (i.e., fasting blood glucose > 200 mg/dL)
-
Patient has a life expectancy of greater than 20 weeks
-
Patient does not have known brain metastases (testing optional)
-
Patient does not have known human immunodeficiency virus syndrome (HIV, testing optional); known HIV-positive patients receiving combination antiretroviral therapy are ineligible because of the potential for pharmacokinetic interactions with triapine
-
Patient does not have a known allergy to compounds of similar or biologic composition as triapine
-
Patient does not have known glucose-6-phosphate dehydrogenase (G6PD) deficiency as the condition interferes with triapine antidote metabolism (G6PD testing optional)
-
Patient is not actively breastfeeding (or has agreed to discontinue breastfeeding before the initiation of protocol therapy)
Exclusion Criteria:
- Patient has another concurrent active invasive malignancy
- Patient has had a prior invasive malignancy diagnosed within the last three years (except [1] non-melanoma skin cancer or [2] prior in situ carcinoma of the cervix); patients are excluded if they have received prior pelvic radiotherapy for any reason that would contribute radiation dose that would exceed tolerance of normal tissues at the discretion of the treating physician
- Patient has uncontrolled intercurrent illness including, but not limited to, symptomatic congestive heart failure, unstable angina pectoris, myocardial infarction within six months of protocol initiation, cardiac arrhythmia within six months of protocol initiation; known inadequately controlled hypertension; clinically significant pulmonary disease including dyspnea at rest, or patients requiring supplemental oxygen, or poor pulmonary reserve; or clinically significant renal function impairment (baseline serum creatinine > 2 mg/dL); or psychiatric illness/social situations that would limit compliance with study requirements
- Patient is receiving another investigational agent for the treatment of cancer
- Patient is currently pregnant
- Patient does not agree to use two forms of birth control if they are of child-bearing potential
- Patients who have had a hysterectomy or are planning to have an adjuvant hysterectomy following radiation as part of their cervical cancer treatment are ineligible (05/30/2017)
- Patients scheduled to be treated with adjuvant consolidation chemotherapy or other anti-neoplastic therapy at the conclusion of their standard chemoradiation (05/30/2017)
- Patients with self-reported or known diagnosis of G6PD deficiency (05/30/2017)
- Patients with vaginal cancer may have previously undergone a hysterectomy for various indications; patients with vaginal cancer who underwent a hysterectomy for treatment of cervical cancer less than five years prior to their diagnosis of vaginal cancer are ineligible
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Arm I (cisplatin, IMRT or RT, brachytherapy)
Patients receive cisplatin IV over 90 minutes on days 2, 9, 16, 23, 30, (and day 36 or 37 at the treating physician's discretion). Patients then undergo EBRT (either conventional RT or IMRT) QD 5 days a week for 25 fractions followed by LDR or HDR brachytherapy according to institution's standards. Treatment continues in the absence of disease progression or unacceptable toxicity. |
Correlative studies Given IV
Otros nombres:
Undergo EBRT
Otros nombres:
Undergo IMRT
Otros nombres:
Undergo brachytherapy
Otros nombres:
Undergo conventional RT
Otros nombres:
|
|
Experimental: Arm II (cisplatin, IMRT or RT, brachytherapy, triapine)
Patients receive cisplatin and undergo EBRT followed by brachytherapy as in Arm I. Patients also receive triapine IV over 2 hours on days 1, 3, 5, 8, 10, 12, 15, 17, 19, 22, 24, 26, 29, 31, and 33. Treatment continues in the absence of disease progression or unacceptable toxicity. |
Correlative studies Given IV
Otros nombres:
Undergo IMRT
Otros nombres:
Undergo brachytherapy
Otros nombres:
Given IV
Otros nombres:
Undergo conventional RT
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Overall Survival (OS) Rate at 3 Years
Periodo de tiempo: At 3 years from randomization.
|
Estimate for probability of overall survival at 3 years by Kaplan-Meier method, where overall survival is defined as the time from randomization to time of death due to any cause or the date of last contact, whichever occurs first. |
At 3 years from randomization.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Progression-free Survival (PFS) Rate at 3 Years
Periodo de tiempo: At 3 years from study randomization.
|
Estimate for probability of progression free at 3 years by Kaplan-Meier method, where progression-free survival is defined as the time from randomization to the date of first documented disease recurrence/progression, death from any cause or date of last contact, whichever occurs first. Recurrence is defined as clinical, radiological or histological evidence of recurrent disease post study treatment. Disease progression will be determined from the physical examinations, which were conducted during treatment (day 9, 16, 23, 30 and 37) and follow-up (1 and 3 months after completing protocol therapy, every 3 months for years 1 and 2, and every 6 months for years 3, 4 and 5), and the PET/CT scan conducted 3 months after the end of treatment. Please note that progression defined using Response Evaluation Criteria in Solid Tumors Criteria (RECIST 1.1) is not required by the protocol. |
At 3 years from study randomization.
|
|
Number of Participants With Adverse Events (Grade 3 or Higher) During Treatment Period
Periodo de tiempo: During treatment period and up to 30 days after stopping the study treatment with a median treatment time as 53 days ranging from 1 to 189 days.
|
Number of participants with a maximum grade of 3 or higher during treatment period. Adverse events are graded and categorized using CTCAE v4.0. |
During treatment period and up to 30 days after stopping the study treatment with a median treatment time as 53 days ranging from 1 to 189 days.
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Number of Participants With Hematologic Toxicity During Treatment Period
Periodo de tiempo: Up to 30 days after completion of study treatment
|
Number of participants with hematologic toxicity during treatment period, where hematologic toxicity is defined as occurrence of any grade 3 or higher adverse events for neutropenia, leukopenia, lymphopenia, anemia, or thrombocytopenia. Adverse events are graded and categorized using CTCAE v4.0. |
Up to 30 days after completion of study treatment
|
|
Number of Participants With Adverse Events (Grade 3 or Higher) That Occurred During Follow-Up Period
Periodo de tiempo: Up to 5 years
|
Number of participants with a maximum grade of 3 or higher that occurred during follow-up period. Adverse events are graded and categorized using CTCAE v4.0. |
Up to 5 years
|
|
Peripheral Blood Methemoglobin
Periodo de tiempo: Baseline to 24 hours after triapine infusion
|
Peripheral blood methemoglobin collected at baseline and 1, 3, 5 and 24 hours after Triapine infusion on Day 1 in Arm II. |
Baseline to 24 hours after triapine infusion
|
|
Metabolic Complete Response (mCR)
Periodo de tiempo: Up to 3 months after completion of treatment
|
The assessment of metabolic complete response is based on the ratio of post 3-month therapy PET/CT maximum standardized update value (SUV) to pre-therapy PET/CT maximum SUV. The metabolic complete response is classified as complete response for a ratio of 0.33 or less, or partial response for a ratio between 0.34 and 0.75, or stable response for a ratio greater that 0.75 but less than 1.25, or progressive response for a ratio greater than 1.25. |
Up to 3 months after completion of treatment
|
|
Intensity Modulated Radiation Therapy (IG-IMRT)
Periodo de tiempo: Up to 60 days.
|
Number of Participants with KBP IG-IMRT |
Up to 60 days.
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Charles A Leath, NRG Oncology
Publicaciones y enlaces útiles
Publicaciones Generales
- Kunos CA, Andrews SJ, Moore KN, Chon HS, Ivy SP. Randomized Phase II Trial of Triapine-Cisplatin-Radiotherapy for Locally Advanced Stage Uterine Cervix or Vaginal Cancers. Front Oncol. 2019 Oct 15;9:1067. doi: 10.3389/fonc.2019.01067. eCollection 2019.
- Kunos CA, Ivy SP. Triapine Radiochemotherapy in Advanced Stage Cervical Cancer. Front Oncol. 2018 May 7;8:149. doi: 10.3389/fonc.2018.00149. eCollection 2018.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimado)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
- Enfermedades urogenitales
- Enfermedades Genitales
- Neoplasias urogenitales
- Neoplasias por sitio
- Neoplasias
- Enfermedades urogenitales femeninas
- Enfermedades urogenitales femeninas y complicaciones del embarazo
- Enfermedades uterinas
- Enfermedades Genitales Femeninas
- Neoplasias Genitales Femeninas
- Enfermedades del cuello uterino
- Neoplasias Uterinas
- Enfermedades vaginales
- Neoplasias del cuello uterino
- Neoplasias vaginales
- Terapéutica
- Fenómeno físico
- Químicos inorgánicos
- Compuestos de cloro
- Compuestos de nitrógeno
- Elementos
- Rieles
- Organizaciones
- Economía y organizaciones de la atención médica
- Metales, pesado
- Compuestos de platino
- Elementos de transición
- Radioterapia, conforme
- Radioterapia, asistida por computadora
- Cisplatino
- Citrato de 1,2-diaminociclohexanoplatino II
- Radioterapia
- Radiación
- Congresos como tema
- Platino
- Radioterapia, modulada por intensidad
- Braquiterapia
- 3-aminopiridina-2-carboxaldehído tiosemicarbazona
Otros números de identificación del estudio
- NCI-2015-00835
- U10CA180868 (Subvención/contrato del NIH de EE. UU.)
- NCI-2015-00835 (Identificador de registro: CTRP (Clinical Trial Reporting Program))
- NRG-GY006 (Otro identificador: CTEP)
- NRG-GY006
- NRG-GY006 (Otro identificador: NRG Oncology)
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .